Sign In  |  Register  |  About Santa Clara  |  Contact Us

Santa Clara, CA
September 01, 2020 1:39pm
7-Day Forecast | Traffic

  • Search Hotels in Santa Clara

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

30.00 -0.14 (-0.48%)
Streaming Delayed Price Updated: 11:53 AM EST, Nov 28, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Pfizer

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
7 F-Rated Stocks to Kick to the Curb in October
Why would you subject your portfolio – and your financial future to F-rated stocks that are likely to drag your earnings down? 
Via InvestorPlace
Why NYSE:PFE is a Top Pick for Dividend Investors.
Why PFIZER INC (NYSE:PFE) is a Top Pick for Dividend Investors. 
Via Chartmill
3 Pharma Stocks to Dump Before the Damage Is Done
There's never a shortage of pharma stocks to sell due to the nature of the sector, especially when compounded by current fears. 
Via InvestorPlace
2 Growth Stocks That Could Rocket Higher Before the End of 2023
Potential approvals of new medicines expected soon could push these stocks through the roof. 
Via The Motley Fool
3 Biotech Stocks Ready to Break Out in 2024
These top three biotech companies are ready to roar into the new year with promising new trials, drugs, and innovative use of AI. 
Via InvestorPlace
Why NYSE:PFE qualifies as a good dividend investing stock.
Analyzing PFIZER INC (NYSE:PFE)'s Dividend Potential. 
Via Chartmill
Why NYSE:PFE provides a good dividend, while having solid fundamentals.
Why the dividend investor may take a look at PFIZER INC (NYSE:PFE). 
Via Chartmill
October’s Stock Market Mojo
October kicks off the last quarter of the year, a time when companies and individuals are busy refining their financial positions and seeking rewarding investment avenues. 
Via Talk Markets
This Is What Whales Are Betting On Pfizer
Via Benzinga
This Could be Novavax's Big Opportunity
Novavax has lagged behind bigger rivals in the vaccine market. 
Via The Motley Fool
Better Growth Stock: Novo Nordisk vs. Pfizer
Which of these two pharmaceutical giants should you add to your portfolio? 
Via The Motley Fool
GSK Cuts Stake In Consumer Healthcare Business Haleon, Raises Around $1B
GSK Plc (NYSE: GSK) said it raised £885.6 million ( 
Via Benzinga
Did Moderna Just Jump Ahead of Rivals in a Potential Billion-Dollar Market?
Moderna, Pfizer, and Novavax all are working on combined vaccine candidates. 
Via The Motley Fool
Small Biotech Promosome Drops Lawsuit Against Pfizer, BioNTech in COVID-19 Vaccine Patent Dispute
Biotech firm Promosome has agreed to end the lawsuit, which accused the COVID-19 vaccine manufacturers, Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX), of patent infrin 
Via Benzinga
Topics Intellectual Property Lawsuit
Exposures COVID-19 Financial Intellectual Property
Balancing Dividends and Fundamentals: The Case of NYSE:PFE.
Exploring PFIZER INC (NYSE:PFE)'s dividend characteristics. 
Via Chartmill
No Merck's COVID-19 Pill - US Government Ceases Free Distribution
The U.S. government is set to cease the distribution of free doses of Merck & Co Inc's (NYSE: MRK) COVID-19 antiviral treatment Lagevrio (molnupiravir), by mid-November, shifting its availability to... 
Via Benzinga
Exposures COVID-19
Why Novavax Stock Fell Today
Novavax, Inc. (NASDAQ: NVAX) shares are trading lower Wednesday amid a pullback in the stock, which gained Tuesday after the FDA granted Emergency Use Authorization for the company's updated... 
Via Benzinga
Exposures COVID-19 Product Safety
Mainz Biomed Continues To Transform Early Cancer Detection Across The Globe
While Pfizer Inc (NYSE: PFE) and Moderna Inc (NASDAQ: MRNA) are making great progress in cancer treatments, the importance of early detection in combating this disease cannot be overstated. 
Via Benzinga
Taylor Swift Boosts Travis Kelce's Popularity: Stocks That Could Benefit From The Love Story
NFL star Travis Kelce's romance with musician Taylor Swift could be a win for brand partners in terms of endorsements and deals. 
Via Benzinga
2 High-Yield Dividend Stocks to Buy in October
These two high-yield dividend stocks are too cheap to ignore. 
Via The Motley Fool
Teva Pharma Hooks Sanofi In $1.5 Billion Inflammation Deal. But Shares Tumble.
The deal leans into the emerging TL1A drug class, potentially rivaling Roivant and Merck. 
Via Investor's Business Daily
Pfizer's Diversity Program Faces Legal Heat, Advocacy Group Revives Discrimination Case
Advocacy group Do No Harm has made a case before the New York-based 2nd U.S. 
Via Benzinga
Cancer Drug Maker 3D Medicines Inc. Trading Higher After Company Announces It Will Repurchase Up To 10% Of Outstanding Shares
3D Medicines Inc. was trading 7.2% higher in the Hong Kong Wednesday morning session at HK$5.53 after the company announced that it is buying back up to 10% of its own stock. 
Via Benzinga
Short Sellers Are Betting Against Novavax (NVAX) Stock
Shorts are betting no one will want Novavax's Covid-19 vaccine, but the pandemic is not yet over, and NVAX stock is cheap. 
Via InvestorPlace
Exposures COVID-19
2 Magnificent Growth Stocks to Buy Right Now
These two biotech stocks could be big winners for patient investors. 
Via The Motley Fool
Sure Winners: 7 Stocks Set to Outperform in the Next Recession
Are you looking to invest in recession proof stocks? Here are seven stocks set to outperform in the next recession. 
Via InvestorPlace
Topics Economy
Exposures Economy
'Traylor' Effect? Pfizer, Campbell's Soup, Other Brands Are Basking In Travis Kelce-Taylor Swift Romance Rumors
EDO's data reveals that a Pfizer campaign featuring Kelce, which started on Sept. 22, experienced a 32% increase in company-related searches. 
Via Benzinga
Novavax Surges After FDA Signs Off On Its Updated Covid Shot, Joining Pfizer, Moderna
The company can now join Pfizer and Moderna in launching an updated booster in the U.S. 
Via Investor's Business Daily
Exposures COVID-19 Product Safety
Novavax Stock Soars On FDA Clearance For Updated Covid-19 Shot: What's Going On?
Novavax Inc (NASDAQ: NVAX) shares are surging Tuesday afternoon after the U.S. 
Via Benzinga
Exposures COVID-19 Product Safety
AstraZeneca Settles Heartburn Treatment Lawsuit For One Of Biggest Selling Drug
AstraZeneca Plc (NASDAQ: AZN) has  
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SantaClara.com & California Media Partners, LLC. All rights reserved.